DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Qin S, Bai Y, Ye S , et al.
Phase III study of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) versus doxorubicin as palliative systemic chemotherapy in advanced HCC in Asian patients.

J Clin Oncol 2010;
28 (15S) : Abstract 4008

Download Bibliographical Data

Search in:
Access: